| Literature DB >> 23844008 |
Rami A Namas1, John Bartels, Rosemary Hoffman, Derek Barclay, Timothy R Billiar, Ruben Zamora, Yoram Vodovotz.
Abstract
We combined in silico, in vivo, and in vitro studies to gain insights into age-dependent changes in acute inflammation in response to bacterial endotoxin (LPS). Time-course cytokine, chemokine, and NO2 (-/)NO3 (-) data from "middle-aged" (6-8 months old) C57BL/6 mice were used to re-parameterize a mechanistic mathematical model of acute inflammation originally calibrated for "young" (2-3 months old) mice. These studies suggested that macrophages from middle-aged mice are more susceptible to cell death, as well as producing higher levels of pro-inflammatory cytokines, vs. macrophages from young mice. In support of the in silico-derived hypotheses, resident peritoneal cells from endotoxemic middle-aged mice exhibited reduced viability and produced elevated levels of TNF-α, IL-6, IL-10, and KC/CXCL1 as compared to cells from young mice. Our studies demonstrate the utility of a combined in silico, in vivo, and in vitro approach to the study of acute inflammation in shock states, and suggest hypotheses with regard to the changes in the cytokine milieu that accompany aging.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23844008 PMCID: PMC3699569 DOI: 10.1371/journal.pone.0067419
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of middle-aged specific mathematical models of inflammation.
|
| Param. |
|
|
|
|
|
| xcp6 | |||||||
|
|
| Influence of TNF onIL-10 (Hill coefficient) | Influence of IL-10 on leukocyte activation (Hill coefficient) | Rate of activation of macrophages due to damage | Activation of macrophages by LPS | Death rate of neutrophils | Activation of neutrophils by LPS | Saturation constant for IL-6′s influence on TNF | |||||||
|
| 8-fold lower | 5-fold lower | 3-fold lower | 9-fold higher | 16-fold higher | 5-fold higher | 11-fold higher | ||||||||
|
|
|
|
|
|
|
|
| ||||||||
|
| Influence of TNF onIL-10 (Hill coefficient) | Regulates levels of IL-10 by modulating production/decay rates | Rate of IL-10 production in response to other cytokines | Death rate of neutrophils | Propensity to produce and secrete IL-6 at rest | Saturation constant for IL-6′s influence on TNF | |||||||||
|
| 3-fold lower | 7-fold higher | 84-fold higher | 4-fold higher | 36-fold higher | 66-fold higher | |||||||||
|
|
|
|
|
|
|
|
| ||||||||
|
| Influence of NO2 −/NO3 − on IL-6 | Death rate of neutrophils | Activation ofneutrophils by LPS | Propensity to produce and secrete IL-6 at rest | Saturation constant for IL-6′s influence on TNF | Saturation constant for IL-6′s influence on macrophage activation | |||||||||
|
| 26-fold higher | 19-fold higher | 6-fold higher | 46-fold higher | 50-fold higher | 3-fold higher | |||||||||
|
|
|
|
|
|
|
|
|
| |||||||
|
| Influence of IL-6 onTNF (Hill coefficient) | Influence of IL-10 onTNF (Hill coefficient) | Influence ofneutrophils on iNOS | Activation ofneutrophils by LPS | Propensity to produce and secrete IL-6 at rest | Saturation constant for TNF’s influence on IL-6 | Saturation constant for influence of LPS on macrophage activation | ||||||||
|
| 1.4-fold lower | 41-fold lower | 6-fold lower | 28-fold higher | 62-fold higher | 73-fold higher | 7-fold lower | ||||||||
|
|
|
|
|
|
|
| |||||||||
|
| Influence ofneutrophils on IL-6 | Death rate of neutrophils | Propensity to produce and secrete IL-10at rest | Saturation constant for IL-6′s influence on TNF | Saturation constant for influence of damage on macrophage activation | ||||||||||
|
| 52-fold higher | 8-fold higher | 4-fold higher | 30-fold higher | 7-fold higher | ||||||||||
Model parameters (constants) changed in the middle-aged specific models are indicated, along with their biological significance. Param.: parameter. Def.: definition.
Figure 1Data and model output for plasma cytokines and NO2 −/NO3 − in young and middle-aged mice subjected to LPS.
Young (C57BL/6; n = 4 animals per time point) and middle-aged mice (n = 4 per time point) were injected with saline or 3 mg/kg LPS as described in Materials and Methods. Plasma concentration as a function of time and age: (A) IL-6, (B) TNF-α, (C) IL-10 and (D) NO2 −/NO3 −. Symbols represent the mean ± SEM (P<0.05, analyzed by Two-way ANOVA followed by Holm-Sidak test for plasma levels of IL-6 and IL-10). For young mice, the line indicates the output of the baseline model of acute inflammation. For middle-aged mice, model re-calibration was carried out as described in the Materials and Methods, yielding five models (colored lines). “Best Model” indicates the model giving the best overall fit to the data.
Figure 2Difference in plasma cytokines and NO2 −/NO3 − in young and middle-aged mice subjected to LPS.
Young (C57BL/6; n = 3–8 animals per time point) and middle-aged mice (n = 4 per time point) were injected with saline or 3 mg/kg LPS as described in Materials and Methods. Middle-aged mice had significantly higher levels of IL-6 (A), TNF-α (B), and IL-10(C) at 60 and 90 min when compared to young mice post-LPS treatment (P<0.05, analyzed by Two-way ANOVA).
Statistically significant plasma inflammatory mediators in both young and middle-aged mice after I.P saline or LPS treatment.
| Treatment | Inflammatory Mediators | Young (mean ± SEM) | Middle-aged (mean ± SEM) |
|
| Saline | GM-CSF | 0 | 20.2±3.5 |
|
| IL-1β | 0 | 21.2±2.9 |
| |
| IL-2 | 2.7±0.2 | 4.8±0.2 |
| |
| IL-4 | 2.8±0.2 | 5.5±0.4 |
| |
| IL-12p40 | 0 | 28.9±2.8 |
| |
| VEGF | 1.2±0.2 | 2.8±0.3 |
| |
| NO2 −/NO3 − | 36.9±1.9 | 22.1±1.1 |
| |
| LPS | IL-6 | 14589.7±1583.9 | 33445.08±7281.9 |
|
| TNF-α | 93.6±18.1 | 332.6±63.7 |
| |
| IL-10 | 251.9±40.3 | 458.9±67.2 |
| |
| MIG/CXCL9 | 100.9±17.5 | 4099.4±690.6 |
| |
| MCP-1 | 18869.1±3153.4 | 34142.9±4515.6 |
| |
| IL-1α | 48.1±6 | 124.5±0.4 |
| |
| IL-17 | 0 | 5.5±0.9 |
| |
| IL-12p40 | 104.1±14.3 | 183.2±21.3 |
| |
| NO2 −/NO3 − | 54.7±4.3 | 34.6±2.3 |
| |
| GM-CSF | 59.4±5.9 | 35.4±4.8 |
|
Young and middle-aged mice (n = 16 each) were treated with either saline or LPS in vivo for 90 min., and circulating inflammatory mediators were assessed as described in Materials and Methods.
Figure 3In vitro cytokine concentrations after in vivo treatment with either saline or LPS in young and middle aged mice.
Young (n = 16) and middle-aged mice (n = 16) were injected with saline or 3 m/kg LPS and peritoneal macrophages were harvested as described in Materials and Methods. Middle-aged mice had significantly higher levels (*P<0.001 vs. young mice) of IL-6 (A), TNF-α (B), IL-10 (C) and KC (D) after in vivo treatment with saline followed by in vitro treatment with culture media. IL-6 (A), TNF-α (B), IL-10 (C), KC (D), IL-2 (E), IL-4 (F) and VEGF (G) concentrations were significantly higher (*P<0.001 vs. young mice) after in vivo LPS treatment followed by in vitro treatment with culture media.
Figure 4Total peritoneal cell count and cell viability.
(A): Middle-aged mice that received in vivo LPS had significantly lower (*P<0.001) cell count when compared to similarly treated young mice. (B): LPS-treated middle-aged mice had significantly lower (*P = 0.008) cell viability when compared to LPS treated young mice.